Health News

Atea Pharma's COVID-19 treatment fails to meet study goal

(Reuters) – Atea Pharmaceuticals said on Tuesday a mid-stage trial testing its experimental COVID-19 treatment failed to meet the main goal of reducing the amount of SARS-CoV-2 virus in patients with mild or moderate disease.

Source: Read Full Article